Ferr-Ease*trade;* delivers unique, patented dual-iron therapy
Ferralet® 90 is different. It now contains Ferr-Ease, a proprietary dual-iron formulation that simply has no substitute. Ferr-Ease delivers a unique blend of ferrous gluconate and carbonyl iron. Why? Because anemic patients are able to start absorbing iron almost as soon as it is delivered. In fact, studies show that the rate of iron absorption increases significantly in anemic patients almost immediately after administration.1 And since ferrous gluconate enters the body ready to be absorbed, it is there when the body needs it.
Carbonyl iron, on the other hand, allows gentle and prolonged solubilization and absorption.2† It is converted from the particulate to soluble ionized iron at a rate determined by the rate of gastric acid production.2 The result is oral iron therapy with excellent tolerability and safety.
In addition, the Ferralet 90 formulation offers many other unique advantages:
- 50 mg docusate sodium gently eases the constipation that can be experienced by patients sensitive to iron therapy
- Vanilla scent addresses the unpleasant taste and smell normally associated with iron therapy
- The formulation is free of lactose and gluten, alleviating common dietary concerns
- 120 mg Vitamin C to enhance iron absorption2
- 1 mg folic acid to bolster the development of red blood cells3
- 12 μg Vitamin B12 to support red blood cell generation4
Displays
NDC 0178-0083-90
Packaged in bottles of 90
Wholesaler Order Entry Numbers
| AmerisourceBergen | 5060280/629182 |
|---|---|
| Bellco | 284554 |
| Burlington Drug Co. | 730614 |
| Cardinal Health, Inc | 4077145 |
| Dakota Drug | |
| Dik Drug | |
| Frank W. Kerr | |
| H.D. Smith | 215-6024 |
| King Drug | |
| Kinray, Inc. | |
| Louisiana Wholesale | |
| McKesson Corp | 1808286 |
| McQueary Bros. Drug Co. | |
| Miami-Luken | |
| Morris & Dickson Co. | 848903 |
| NC Mutual Drug Co. | 665869 |
| Rochester | |
| Smith Drug Co. | |
| Valley Wholesales | 378927 |
| Value Drug Co. |
WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
Ferralet® 90 is a prescription iron supplement approved for treating anemias that respond to oral iron therapy. Your doctor may prescribe Ferralet® 90 if you have certain anemias associated with pregnancy, blood loss, or metabolic disease, or if you are recovering from surgery or do not have enough iron in your diet.
Important Safety Information
Ferralet® 90 has not been tested in children. Dosing for elderly patients should begin at the lower end of the dosing range.
Talk to your doctor before taking Ferralet® 90 if you have a known sensitivity to any of its ingredients.
Because some medications may interact with Ferralet® 90, you should tell your doctor about any medications you are taking, including antacids and antibiotics.
Before prescribing iron therapy, your doctor will need to determine the type of anemia you have and identify its underlying causes. You should not take this product if you have been diagnosed with hemolytic anemia or an iron overload disorder such as hemochromatosis or hemosiderosis.
If you have certain forms of anemia associated with vitamin B12 deficiency (i.e. pernicious anemia), the Folic acid contained in Ferralet® 90 is not enough to treat your condition. Doses of more than 0.1 mg Folic acid per day can hide the symptoms of these anemias, so your doctor must rule them out before prescribing this product.
Once you begin iron therapy with Ferralet® 90, take the product 2 hours after meals, and do not exceed the recommended dose.
When taking Ferralet® 90, you may experience temporary side effects such as GI irritation, constipation, diarrhea, nausea, vomiting, and dark stools.
Some patients taking Folic acid have reported allergic reactions. Additionally, Ferralet® 90 contains FD&C Yellow No. 5 (tartrazine), which may cause allergic reactions (including bronchial asthma) in certain susceptible people. Although uncommon, tartrazine sensitivity is often seen in patients who also have aspirin hypersensitivity. Contact your doctor and discontinue use if you develop any unusual symptoms.
Keep this product out of reach of children. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six. Symptoms of overdose include abdominal pain, metabolic acidosis, decline or absence of urine production, nerve damage, coma, convulsions, death, dehydration, congestion of blood vessels, cirrhosis of the liver, low blood pressure, hypothermia, fatigue, nausea, vomiting, diarrhea, black or tarry stools, vomiting blood, rapid heart rate, high blood sugar, drowsiness, abnormal pale or bluish skin color, lack of energy, seizures, and shock. In case of accidental overdose, call a doctor or poison control center immediately.
To report negative side effects, contact Mission Pharmacal Company at 1-800-298-1087 or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
* US Patent no. 6,521,247 B1
† Based on animal studies.
- Lynch SR, Stoltzfus RJ. Iron and ascorbic Acid: proposed fortification levels and recommended iron compounds. J Nutr. 2003 Sep;133(9):2978S-84S.
- Folic acid [Internet]. WebMD; [updated 2007 Mar 5; accessed 2009 17 Dec]. Available from http://www.webmd.com/diet/folic-acid.
- Vitamin B12 [Internet]. MayoClinic.com; [cited 2009 17 Dec]. Available from http://www.mayoclinic.com/health/vitamin-B12/NS_patient-vitaminb12.
